Reddit Posts
Next Tuesday, Houston federal court judge hears SCLX vs the big bad Investment banks on ILLEGAL NAKED SHORTING. SHOW ME THE ILLEGAL PROFITS
SCLX stock collapse by shorts 50% drop <2 trading days
SCLX from $11 pre-market to $15. Shorters are desperate and failing
SCLX/SRNEQ Federal Judge subpoenas delivered to 25 brokers for disclosure of shorts by 4/14 COB
While the band of pumpers pump the same loser stocks that go nowhere (NVOS, TRKA, PXMD etc.), I call another big winner in BANL
SCLX a meme stock speculation or maybe SCLXW
SCLX ... lots of shorts and naked shorts ... SCLX and courts file to hold brokerages accountable
SCLX Might be the Short Squeeze Meme Traders Have Been Waiting For
SCLX unaccounted for restricted shares non marginable may be used to short SCLX ?
SCLX SHORT SQUEEZE? Anyone have information
SCLX looks legit - brokers legally forced to report due to SRNEQ bankruptcy
How About The Massive Move From $SCLX GUYS 🔥 We Seen This One Coming A Mile Away ! Holy Smokes , Right After $IFRX 🔥
SCLX just started today. Judge order initiated. You still have time to jump on the bandwagon.
SCLX is a major short squeeze in beginning....
SRNE / SCLX is this a squeeze in the making?
$SCLX - Company trying to engineer mother of short squeezes here
Mentions
SCLX has been doing really well for me
I already have my nuts drenched in that crap down 60% on my SCLX and 99.9% on my SRNE investment.
$SCLX buy now, earning announcement coming up on 11/14. Currently @ $.86 per share
SCLX! Non opioid pain medications.
Absolutely: Scilex Holding Company (SCLX) is currently experiencing positive sentiment, with technical indicators suggesting a bullish outlook. The stock's RSI values indicate it's nearing overbought territory, but the MACD histogram shows strong upward momentum, supporting potential gains. The 10-day SMA at $0.953 and the current price of $1.02 suggest a breakout above recent averages, aligning with broader market optimism driven by anticipated rate cuts. However, the lack of trading volume today raises caution about liquidity and potential volatility. Given the positive sentiment and technical setup, consider a LONG position with an entry around $1.02. Set the first price target at $1.10 and a second at $1.15, with a stop loss at $0.95 to manage downside risk. Confidence in reaching the first target is moderate due to strong momentum, while the second target carries lower confidence given potential market volatility.
Absolutely: LCID: Lucid Group, Inc. (LCID) is currently trading at $2.275, with a mixed sentiment but a slight positive tilt due to the recent $1 billion investment by the Saudi sovereign wealth fund and a 14% sales growth from September to October. The stock is heavily shorted, with 25% of the float shorted, indicating potential for a short squeeze, especially with the upcoming earnings report on November 7th. Technical indicators show a bearish trend, with the RSI below 30, suggesting the stock is oversold, while the MACD histogram is negative, indicating downward momentum. The broader market shows cautious optimism, which could support LCID if tech sector strength continues. For today's session, consider a LONG position with an entry price around $2.25, targeting $2.40 as the first target and $2.55 as the second, with a stop loss at $2.15. Confidence in reaching the first target is moderate due to potential short squeeze dynamics, while the second target is less certain given the current bearish technicals. Keep an eye on broader market movements and any news related to Lucid's production expansion or upcoming earnings for further insights. SCLX: Scilex Holding Company (SCLX) is currently experiencing positive sentiment, with technical indicators suggesting a bullish outlook. The stock's RSI values indicate it's nearing overbought territory, but the MACD histogram shows strong upward momentum, supporting potential gains. The 10-day SMA at $0.953 and the current price of $1.02 suggest a breakout above recent averages, aligning with broader market optimism driven by anticipated rate cuts. However, the lack of trading volume today raises caution about liquidity and potential volatility. Given the positive sentiment and technical setup, consider a LONG position with an entry around $1.02. Set the first price target at $1.10 and a second at $1.15, with a stop loss at $0.95 to manage downside risk. Confidence in reaching the first target is moderate due to strong momentum, while the second target carries lower confidence given potential market volatility. MAXN: Maxeon Solar Technologies (MAXN) is experiencing heightened volatility, driven by mixed sentiment and potential short squeeze dynamics. The stock's RSI values indicate overbought conditions, suggesting caution for new long positions. Recent price action shows a strong upward trend, with the current price at $9.69, significantly above key moving averages, indicating bullish momentum. However, skepticism about the company's fundamentals and negative margins could limit upside potential. Given the broader market's cautious optimism and MAXN's speculative nature, a short-term long position could be considered with an entry around $9.50. Target the first price at $10.50 and a second at $11.00, with a stop loss at $8.80 to manage downside risk. Confidence in reaching the first target is moderate due to potential short squeeze effects, while the second target carries lower confidence given fundamental concerns.
LCID, SCLX, MAXN please and thank you!!
It’s way at the bottom under the subscribe button. I like SCLX too, but it’s worth noting the bias of the website/article. I would take this into consideration with anything this website puts out. Anyway,I copied the text below. “Huge Alerts has been compensated by CDMG Inc for the total sum of $350,000.00 This agreement is for the marketing of Scilex Holdings (NASDAQ:SCLX) which services include the issuance of this release and other opinions that we release concerning of Scilex Holdings (NASDAQ:SCLX). Huge Alerts has not investigated the background of CDMG Inc the hiring party, or Scilex Holdings (NASDAQ:SCLX) Anyone viewing this newsletter should assume CDMG Inc or affiliates of CDMG inc own shares of Scilex Holdings (NASDAQ:SCLX) which they plan to liquidate, and further understand that the liquidation of those shares may or may not negatively impact the share price. Huge Alerts has received this amount as a production budget for advertising efforts and will retain amounts over and above the cost of production, copywriting services, mailing and other distribution expenses as a fee for our services. As such, our opinion is neither unbiased nor independent, and you should consider that when evaluating our statements regarding Scilex Holdings (NASDAQ:SCLX)”
November on through the first quarter 2025 seems to be extremely bullish from my research. Stock Price Target SCLX High $14.00 Median $10.00 Low $5.50 Average $9.88 Current Price $1.00
Great idea, though I can't seem to find $SCLX
SCLX: https://scilexholding.gcs-web.com/node/9436/html https://scilexholding.gcs-web.com/news-releases/news-release-details/scilex-pharmaceuticals-inc-wholly-owned-subsidiary-scilex
SCLX: https://scilexholding.gcs-web.com/news-releases/news-release-details/scilex-pharmaceuticals-inc-wholly-owned-subsidiary-scilex https://scilexholding.gcs-web.com/node/9436/html HINT: 🚀🚀🚀
Scilex Holding Company (SCLX) is currently trading at $1.03, showing a bullish momentum with recent news addressing manipulative short selling and a strategic dividend announcement that could enhance shareholder value. The technical indicators are supportive, with the 10-day SMA at $0.94 and the 8-day EMA at $0.94, both above the current price, suggesting potential upward movement. The RSI levels indicate moderate strength, not yet overbought, while the MACD histogram shows positive divergence, hinting at continued bullish momentum. Given the broader market’s resilience and SCLX’s proactive measures, an entry around $1.02 is advisable. Set the first price target at $1.10 with a confidence level of 70%, considering the positive sentiment and technical setup, and a second target at $1.15 with a 60% confidence level, factoring in potential volatility from broader market influences. A stop loss at $0.98 is prudent to manage downside risk. Overall, SCLX presents a compelling opportunity for day traders looking to capitalize on its current momentum and strategic initiatives.
SCLX: Non opioid pain relief. Opioids are a big problem and this mess is starting to get cleaned up. The solution is to have options and I believe Scilex will provide those options for chronic pain.
Loaded up on SCLX and TNXP for the short squeeze play. SCLX has some potential for a short squeeze, with growing short interest and a relatively small float, making it an interesting speculative play. I'm 80/20 on it, TNXP isn't as high potential for squeeezeee.
Parent company is sorrento and the reason the dividend shares are locked up is because they burned their shareholders and then “gifted” them SCLX shares, have been pushing the dividend back consistently too when each lockup approaches, this company had serious potential but the share price has been decimated, potentially some upside but I’d be cautious
Of course: Scilex Holding Company (SCLX) is showing signs of bullish momentum, with the current price at $0.9601 and a recent uptick in trading volume, although still below its 65-day average. The technical indicators suggest a positive outlook: the 8-day EMA ($0.9202) is above the 20-day EMA ($0.9150), and the MACD histogram is positive, indicating potential upward momentum. The RSI is nearing overbought territory at 69.5, suggesting caution but not yet signaling a reversal. Given the broader market’s cautious optimism, SCLX could benefit from sector rotation into healthcare. For today’s session, consider entering around $0.95, with a first target at $1.00 and a second target at $1.05, setting a stop loss at $0.92 to manage risk. Confidence in reaching the first target is moderate due to the positive technical setup, while the second target carries lower confidence given potential resistance and broader market volatility.
Can you tell us a little on SCLX
SCLX is looking quite interesting…
You missed the punch line, "SEMDEXA", non-opioid pain med. Has met all of the end points and is getting ready to finish the testing regimen. This is the crown jewel in the SCLX stable. How much is the first major non-opioid pain med for sciatica that appears to be superior to the current opioid meds.
You also get a 10% divy in stock of SEMNUR shares a spac merger with Denali acquisition for every SCLX share you own in early 2025.
might not mean shit but on Trading212 for a brief moment this morning a little yellow notice appeard stating that $SCLX was not tradable, it was only on screen for a minute or two then vanished.
Pfff...SCLX has 11M shares in the hands of the shorts .this is not good at all.
**$SCLX** agree... this stock has huge potential
Scilex Holding Company ( SCLX SCLXW ) has a market cap of $234 million, and the subsidiary is valued at $2.5 billion?
Silex $SCLX is once again in oversold territory and might be turning back up? If it closes above 1.30 that would be the sign it's time to buy. If you played it right over the past year, you would have made 100% four times!
SCLX: Possible dividend in play, insider buying, and now this- https://finance.yahoo.com/news/scilex-holding-company-announces-collaboration-130000600.html
Silex $SCLX just signed a deal with ACEA Therapeutics to distribute their non-narcotic chronic pain medications in China, opening up a huge potential market. This stock currently trades just under 2.00 but not for long
Silex $SCLX is trading close to yesterday's close under a lot of downward manipulation. Right now may be your last chance to buy this great company under 2.00. Just read the most recent PR that sent this stock to 2.73 after hours. It will be back there again soon
>for up to 2 billion (lol). "subject to adjustment based on third-party fairness opinion" SCLX has a market cap of $345 million. Wonder what third party would think one of SCLX's subsidiaries is worth $2 billion?
[DECA with a quick turnaround, LOI with SCLX (who also SPACed) subsidiary for up to 2 billion (lol).](https://www.globenewswire.com/news-release/2024/07/02/2907841/0/en/Semnur-Pharmaceuticals-Inc-a-Wholly-Owned-Subsidiary-of-Scilex-Holding-Company-and-Denali-Capital-Acquisition-Corp-Nasdaq-DECA-Enter-into-a-Letter-of-Intent-for-a-Proposed-Business.html)
Silex $SCLX continues to march forward. If you didn't add some shares when I was talking about it at .80 it's not too late. It's currently 2.03 and expected to go over 3.00 by the end of July. This Friday they will ring the NASDAQ bell. Won't be a penny stock for long IMO
Can someone buy my instant profit SCLX $2 6/21 put? I have no capital to exercise. $0.20
Can someone buy my instant profit SCLX $2 6/21 put? I have no capital to exercise. $0.20
Correction on the way for SCLX
SCLX Naked short squeeze started todayemote:free\_emotes\_pack:upvote
All of y'all who downvoted me on SCLX we hit $2. ( Posted about the company when it was at $0.90) Eat a frank 
Ive been downvoted to oblivion for posting about SCLX since it was $0.90 ..... We hit $1.80 today 
Another 11% day on SCLX Gave you guys a mini DD yesterday.
(3rd Reddit account so not enough Karma to make a post so Ill just leave it here ) Scilex Holding Company released/launched its 3rd commercial product, "GLOPERBA" on Monday (June 10th, 2024) which is looking fairly successful. Some background on SCLX if you've never heard of them. Scilex Holding Company develops and commercialize non opioid pain medications for minor to severe pain. Right now (and past couple years) we have seen a consistent increase in Opioid addiction and overdoses. It will only get worse from the looks of it. They have already shipped their new product to many National and Independent Drugstores/Pharmacies. Below I will leave info on what the product/medicine is and what it treats. ""GLOPERBA will be the first oral liquid medicine for prophylaxis of gout flares available beginning this week with a WAC Price of $595/bottle."" and theyre ""Gout is a painful arthritic disorder affecting an estimated 9.2 million people in the United States^(1). As gout cases increase every year, treatment requirements increase. The gout treatment market is projected to be $2.0 billion in the U.S. by 2028 "" (I also left a link to a article talking about the opioid crisis a little bit. "Fourth wave") ""The United States is knee-deep in what some experts call the opioid epidemic’s “fourth wave,”"
SCLX is seeing some nice movement today. Wonder if it will stay that way until EOW.
Tomorrow, SCLX: https://scilexholding.gcs-web.com/news-releases/news-release-details/scilex-holding-company-announces-us-fda-has-approved-snda
SCLX. A producer of revolutionary non-opioid pain relief medicine. Stock went from 16 to 1.10 because of the naked short selling.
We need these companies on the SHO list to follow this lead https://finance.yahoo.com/news/scilex-holding-company-sends-letter-130000733.html PALO ALTO, Calif., May 24, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focu...
SCLX to $3-$4 by end of June 
Not too late to pick up Scilex $SCLX. I've been posting here since it was around .80, now 1.19. But it's got a long way to run. Non-narcotic pain meds very popular with pain specialists and patented patch technology
SCLX is looking like a great buy right now
SCLX is going to have some nice movement come Tuesday. 
Just announced "Scilex ($SCLX) will be added to the MSCI Global Micro Cap Index as of the close of market on Friday, May 31, 2024."
(SCLX) Thoughts on this letter? [https://ml.globenewswire.com/Resource/Download/0a05a41f-47b1-4b67-8aac-38492551a6ce](https://ml.globenewswire.com/Resource/Download/0a05a41f-47b1-4b67-8aac-38492551a6ce)
Article today in Simply Wall St says insiders are buying and holding Silex $SCLX. 1 YR est is now at 7.00. Currently trading at 1.08
Scilex #SCLX is moving up today. I've been telling folks for awhile this has been oversold and slowly taking off. Now filings indicate several company officers have bought hundreds of thousands of shares. Not to late to get in at 1.20. This is headed back over 2.00
Scilex $SCLX CEO and other company officers just bought hundreds of thousands of shares. This stock has been moving up from a deeply oversold position and could quickly double on positive news.
Scilex #SCLX is breaking out of its oversold bottom. Soon above $1.00, headed to $2.00. Read their recent press release summarizing their pipeline
Scilex #SCLX has been pretty flat but seems to have finally hit an oversold bottom and now coming back up. If it returns to its pre dilution level it would be a 200% run up
Hit up SCLX… https://scilexholding.gcs-web.com/news-releases/news-release-details/scilex-holding-company-provides-information-scilex-stockholders
Scilex $SCLX has adjusted for the recent dilution and has been coming back from its oversold bottom of .82. Should close above 1.00 this week. The company makes a non-narcotic pain patch which has been approved and being sold for specific uses. They are currently applying for approval for osteoarthritis, which would be huge.
Scilex $SCLX continues to move up off its oversold position. Should go above 1.00 soon then back up to 2.00. They have approved drugs and royalties from their patents
Scilex $SCLX is moving up again off an oversold position. They have approved non-narcotic pain meds and successfully defended their patents against big pharma recently.
Silex $SCLX back above 1.00. Next stop 2.00. I was posting about it at .88
SCLX continues to move up off the bottom. News of FDA approval for ZTlido for osteoarthritis could make this rocket
Silex $SCLX is deeply oversold and coming up off the bottom. They have a non-narcotic pain patch already approved for some conditions. Currently seeking approval for osteoarthritis. That news would be huge. Plus they've defended their patented patch technology and won settlements with big pharma including ongoing royalties.
what are the chances for SCLX to have a short squeeze
Silex $SCLX is deeply oversold after dilution. They have several drugs on the market already and receive royalties from big pharma that use their patented patch. I'm picking up more at these fire sale prices
SCLX is one to watch. Silex has several drugs on the market including non-narcotic pain meds. They have a unique patch and recently successfully defended their patents against 2 big pharma. They won cash awards and get ongoing royalties. The stock has been beaten down due to dilution but looks to have hit bottom.
Looking into this, it seems that the restriction on SCLX shares expires on March 31, 2024 [https://cash.app/help/us/en-us/061726-SRNE-SCLX-stock-dividend](https://cash.app/help/us/en-us/061726-SRNE-SCLX-stock-dividend) I've had stock shares distributed to me in the past when a company is spun out, but there were no restrictions on the shares I received. It is unclear why any restriction was placed on them in the first place, nor why the restriction was extended from the original unknown date to 12/1/2023 and then again to 3/31/2024.
Vrtx should buy Scilex (SCLX)
I will not rush out buying, I will just give the market 2 extra days to stop leaking the yearly wallets closers…but MVIS, SCLX, IMMX, ARDX , TUP, ACRS , NEWEGG , PFIF , SMMT, ANY , LITM , ACXP and MTC those are under watch for me next 3 months
Scilex Holding Company ( SCLX SCLXW ) put out a couple of press releases announcing there had been some naked short selling of shares held by Sorrento last Wednesday, offering to allow those shorts to close their positions by October 31, [posted those here](https://www.reddit.com/r/SPACs/comments/16zgazj/comment/k3gxc0k/) at the time. SCLX up about 70%, from $1.24 last Wednesday.
[Scilex Holding Company Provides Notice to All Record Holders and Beneficial Owners of Restricted Shares of Scilex Holding Company](https://www.globenewswire.com/news-release/2023/10/03/2753697/0/en/Scilex-Holding-Company-Provides-Notice-to-All-Record-Holders-and-Beneficial-Owners-of-Restricted-Shares-of-Scilex-Holding-Company.html) \- SCLX SCLXW [Scilex Holding Company Provides Notice to All Lenders of Short Positions in the Restricted Dividend Shares of Scilex Holding Company](https://www.globenewswire.com/news-release/2023/10/04/2754860/0/en/Scilex-Holding-Company-Provides-Notice-to-All-Lenders-of-Short-Positions-in-the-Restricted-Dividend-Shares-of-Scilex-Holding-Company.html) Interesting couple of press releases in the past two days from SCLX. Sorrento Therapeutics, Inc declared bankruptcy in February. Previously, Sorrento had issued a dividend of 76,000,000 shares of common stock of Scilex Holding Company to Sorrento shareholders. Those shares are locked up through March 2024. But it seems quite a few SCLX shares were sold short using that restricted stock. "According to Sorrento’s estimates, **approximately 8.4 million or more shares** of Scilex common stock were deemed to have been sold “short” as of the Payment Date as a result of the “short” positions of the underlying Sorrento common stock. “Naked short” sales or “naked short” positions in any Scilex common stock may constitute a violation of SEC Regulation SHO." "**On June 14, 2023, the Bankruptcy Court entered a temporary restraining order temporarily suspending all short sales of Scilex Dividend Stock** and ordering the defendants to provide an accounting of all profits received from the naked short selling of Scilex Dividend Stock and Scilex common stock, including all interest charged to short sellers, no later than five business days after entry of the order. On July 18, 2023, the Bankruptcy Court then granted the joint emergency motion filed by the Debtors and the Equity Committee for an order (i) approving and authorizing the Debtors to consummate an offering of shares of Scilex common stock held by the Debtors, (ii) authorizing entry into settlement agreements with participating record holders of Scilex common stock who opt into a settlement, and (iii) granting related relief. This emergency motion was very successful, resulting in settlements reached with dozens of short sellers and **approximately 800,000 Scilex common stock short positions closed or covered**. While certain parties with short positions in the Scilex Dividend Stock (“Short Sellers”) settled with the Debtors in the Bankruptcy Proceedings as described in the paragraph immediately above, a number of Short Sellers who engaged in illegal naked short selling or violated the terms of the transfer restrictions imposed on the Scilex Dividend Stock have not yet elected to opt into a settlement. " Sounds like approximately 7.6 million short shares still need to be covered, and the only way to cover may be to buy SCLX common stock off the open market and convert it to the restricted dividend stock. "Deadline to Participate. This Proposal shall commence on October 6, 2023 and continue to and end on October 27, 2023."
I have 5k invested at .34c and dumped my SCLX shares at $3 bought at $5.
look at SCLX founder, or the SRNE one I forget which but the dude is a serial fraudster. He's got news articles from other fraud from years back. I'd avoid this but who knows maybe it goes up a thousand %
Tried to share info here before but your damn bots are attack dogs—interesting stuff-and worth the read. This is about Sorrento Therapeutics (SRNEQ) and Scilex (SCLX) going after brokers for allowing naked shorting and have involved a Fed judge now to stop shorting Scilex (read the filing to better understand how unique this situation really is if you’re interested.) Can’t make this sh*t up. Do your own DD: https://cases.stretto.com/public/x228/12086/PLEADINGS/1208606122380000000116.pdf https://cases.stretto.com/public/x228/12086/PLEADINGS/1208606142380000000068.pdf
I like this stock..Looks like Robinhood is at it again..they wont price SCLX shares for its rightful owners https://preview.redd.it/1gesqjf4ax1b1.png?width=1336&format=png&auto=webp&v=enabled&s=b0ab5f34b6effc38e2e2dcebe350fabe40c5c2bd